Naveen Krishnan, Mirae Asset Capital Life Science managing director
Investment firm Mirae launches its US biotech VC fund with $50M
A new biotech venture capital firm emerged Thursday with $50 million to back as many as eight private life sciences startups.
The firm, Mirae Asset Capital Life Science, is a US affiliate of the large Mirae Asset Financial Group, which has nearly $600 billion in assets under management. While it’s been an investor in biotechs like BioNTech and Vividion over the years, the new firm said it is the first and only US affiliate of the sprawling Mirae.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
